Kobayashi, N., Abedini, M., Sakuragi, N., & Tsang, B. K. (2013). PRIMA-1 increases cisplatin sensitivity in chemoresistant ovarian cancer cells with p53 mutation: A requirement for Akt down-regulation. BioMed Central.
Citación estilo ChicagoKobayashi, Noriko, Mohammadreza Abedini, Noriaki Sakuragi, and Benjamin K. Tsang. PRIMA-1 Increases Cisplatin Sensitivity in Chemoresistant Ovarian Cancer Cells With P53 Mutation: A Requirement for Akt Down-regulation. BioMed Central, 2013.
Cita MLAKobayashi, Noriko, Mohammadreza Abedini, Noriaki Sakuragi, and Benjamin K. Tsang. PRIMA-1 Increases Cisplatin Sensitivity in Chemoresistant Ovarian Cancer Cells With P53 Mutation: A Requirement for Akt Down-regulation. BioMed Central, 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.